XML 48 R34.htm IDEA: XBRL DOCUMENT v3.22.4
FAIR VALUE MEASUREMENTS - Manhattan Pharmaceuticals, Inc. (Details)
$ / shares in Units, $ in Millions
1 Months Ended 12 Months Ended
Mar. 31, 2010
USD ($)
item
$ / shares
Dec. 31, 2022
Dec. 31, 2021
Convertible Notes Payable [Member]      
Fair Value Measurements      
Det instrument rate   5.00% 5.00%
Manhattan and Ariston Pharmaceuticals Merger [Member]      
Fair Value Measurements      
Notes Issued | $ $ 15.5    
Debt Instrument, Term 5 years    
Det instrument rate 5.00%    
Debt Instrument convertible conversion price | $ / shares $ 1,125    
Percentage Of Cash Proceeds From Operation To Repay Convertible Debt 5.00%    
Number of Obligations | item 0